Laddar...
The Bioequivalence of Two Peficitinib Formulations, and the Effect of Food on the Pharmacokinetics of Peficitinib: Two‐Way Crossover Studies of a Single Dose of 150 mg Peficitinib in Healthy Volunteers
The marketed tablet formulation of peficitinib differs from the tablet used during the clinical trials. The bioequivalence of the marketed formulation and developmental tablet, and the food effect on the marketed formulation, were analyzed in 2 Japanese open‐label, randomized, 2‐way crossover studie...
Sparad:
| I publikationen: | Clin Pharmacol Drug Dev |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984322/ https://ncbi.nlm.nih.gov/pubmed/32618438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.843 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|